EUVIMEDEUVIMED entdecken
Crossref

An Endogenously Gated DNA Nanodevice Enables Mitochondria-Specific FEN1 Monitoring in Response to Therapeutic Challenge

Lie Li, Baozhu Hu, Chang Liu, Yu Wang, Bin Ning, Xuerui Zhang, Jin Jiao iD

ACS Sensors · 06.11.2026

DOI: 10.1021/acssensors.6c03035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Sensors, online erschienen am 06.11.2026. Verfasst von Lie Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Central Hospital Affiliated to Shandong First Medical University, School of Clinical and Basic Medical Sciences, School of Pharmacy, Integrative Cent…. Die Arbeit nennt 43 Literaturangaben. Gefördert von: Key Technology Research and Development Program of Shandong Province, Changping Laboratory, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Monitoring therapy-induced molecular changes within subcellular compartments is crucial for understanding cellular stress and providing clues to treatment response. Mitochondrial base excision repair (BER) enzymes have emerged as promising indicators of therapeutic response, yet effective tools for their on-site and dynamic monitoring remain scarce. Here, we report an endogenously gated DNA nanodevice (EGDN) capable of real-time, mitochondria-specific monitoring of flap endonuclease 1 (FEN1), a key BER enzyme, under therapeutic challenge. The EGDN remains silent during transport and is sequentially activated by the mitochondria-encoded ribosomal RNA and FEN1, thus achieving spatial control over FEN1 imaging. This conditional regulation pattern reduces nonspecific signals and sharpens the spatial resolution of FEN1 visualization within mitochondria. We further demonstrate that EGDN dynamically tracks mitochondrial FEN1 fluctuations in tumor cells undergoing chemotherapy or radiation therapy, providing a molecular readout of treatment-associated alterations. Collectively, this work establishes a robust biosensing toolbox for dissecting the BER process at the subcellular level, with broad implications for cancer early diagnosis and targeted therapy.

Schlagwörter

Stichwörter der Autor:innen

DNA nanodeviceendogenously gatedmitochondrial FEN1monitoringtreatment-related alterations

Autor:innen und Institutionen

  • Central Hospital Affiliated to Shandong First Medical University, School of Clinical and Basic Medical Sciences, School of Pharmacy, Integrative Center for Frontier Biotech and Pharmaceutical Sciences, Shandong First Me…

ORCID-Profile: Jin Jiao

Förderung

  • Key Technology Research and Development Program of Shandong Province
  • Changping Laboratory
  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province
  • Taishan Scholar Project of Shandong Province
  • Shandong First Medical University
  • Shandong Academy of Medical Sciences

Zitieren

APA

Li, L., Hu, B., Liu, C., Wang, Y., Ning, B., Zhang, X., & Jiao, J. (2026). An Endogenously Gated DNA Nanodevice Enables Mitochondria-Specific FEN1 Monitoring in Response to Therapeutic Challenge. ACS Sensors. https://doi.org/10.1021/acssensors.6c03035

Vancouver

Li L, Hu B, Liu C, Wang Y, Ning B, Zhang X, et al. An Endogenously Gated DNA Nanodevice Enables Mitochondria-Specific FEN1 Monitoring in Response to Therapeutic Challenge. ACS Sensors. 2026. doi:10.1021/acssensors.6c03035

BibTeX
@article{Li2026,
  author = {Li, Lie and Hu, Baozhu and Liu, Chang and Wang, Yu and Ning, Bin and Zhang, Xuerui and Jiao, Jin},
  title = {An Endogenously Gated DNA Nanodevice Enables Mitochondria-Specific FEN1 Monitoring in Response to Therapeutic Challenge},
  journal = {ACS Sensors},
  year = {2026},
  doi = {10.1021/acssensors.6c03035}
}
Kostenlos starten →